Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IAC vs IA induction for AML
NCT02323022Phase 3Completed
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Dec 2014
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cladribine in acute myeloid leukemia (AML), sponsored by First Affiliated Hospital of Soochow University. Started Dec 2014; status: completed.
02
Drugs
cladribine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02323022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02323022.